CymitQuimica logo

CAS 609799-22-6

:

Tasimelteon

Description:
Tasimelteon is a synthetic compound primarily recognized for its role as a melatonin receptor agonist, specifically targeting the MT1 and MT2 receptors. It is classified as a non-benzodiazepine sleep aid and is primarily used in the treatment of circadian rhythm sleep disorders, particularly in individuals who are blind and experience non-24-hour sleep-wake disorder. The molecular formula of Tasimelteon reflects its complex structure, which includes multiple functional groups that contribute to its pharmacological activity. The substance is typically administered orally and has a relatively short half-life, necessitating careful dosing to achieve desired therapeutic effects. Its efficacy is attributed to its ability to mimic the action of melatonin, a hormone that regulates sleep-wake cycles. Additionally, Tasimelteon has undergone various clinical trials to assess its safety and effectiveness, demonstrating a favorable profile for managing sleep-related issues without the sedative side effects commonly associated with traditional sleep medications. As with any pharmacological agent, potential side effects and contraindications should be considered when prescribing Tasimelteon.
Formula:C15H19NO2
InChI:InChI=1S/C15H19NO2/c1-2-15(17)16-9-10-8-13(10)11-4-3-5-14-12(11)6-7-18-14/h3-5,10,13H,2,6-9H2,1H3,(H,16,17)/t10-,13+/m0/s1
InChI key:InChIKey=PTOIAAWZLUQTIO-GXFFZTMASA-N
SMILES:C(NC(CC)=O)[C@H]1[C@@H](C1)C2=C3C(=CC=C2)OCC3
Synonyms:
  • (1R-trans)-N-[[2-(2,3-Dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
  • Bms 214778
  • Hetlioz
  • N-[[(1R,2R)-2-(2,3-Dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
  • N-{[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide
  • Propanamide, N-[[(1R,2R)-2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]-
  • Vec 162
  • MA 1
Found 10 products.